7-Bromoquinolin-8-ol

Catalog No.: 
ACYCDG687
CAS No.: 
13019-32-4
Molecular Formula: 
C9H6BrNO
Molecular Weight: 
224.06
7-Bromoquinolin-8-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$61.00In stockIn stock
5g95%$216.00In stockInquiry
10g95%$345.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromoquinolin-8-ol
IUPAC Name7-bromoquinolin-8-ol
MDL No.MFCD01250025
Molecular FormulaC9H6BrNO
Molecular Weight224.06
SMILESOC1=C2N=CC=CC2=CC=C1Br
InChI KeyICKPMTNGWVNOGC-UHFFFAOYSA-N
SynonymDTXSID20327640 | NCI60_026022 | DS-15452 | 8-quinolinol, 7-bromo- | 7-bromoquinolin-8-ol | A888781 | InChI=1/C9H6BrNO/c10-7-4-3-6-2-1-5-11-8(6)9(7)12/h1-5,12 | SB71495 | CS-W006481 | SY102135 | 7-Bromo-8-hydroxyquinoline | MFCD01250025 | ICKPMTNGWVNOGC-UH
CAS No.13019-32-4
PubChem CID384161

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACYCDG687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACARDH809 route compound structure diagram
    ACARDH80936748-99-9In Stock
  2. Then
  3. ACYCDG687 route product structure diagram
    ACYCDG68713019-32-4In Stock
Inquiry

2. ACYCDG687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBEOA740 route compound structure diagram
    ACBEOA74025387-93-3
  4. Then
  5. ACYCDG687 route product structure diagram
    ACYCDG68713019-32-4In Stock
Inquiry

3. ACYCDG687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYCDG687 route product structure diagram
    ACYCDG68713019-32-4In Stock
Inquiry

Comments (0)